From Texas Health and Human Services Commission <[email protected]>
Subject Agenda for April Drug Utilization Review Board Meeting Now Available
Date April 7, 2023 1:02 PM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
Texas Health and Human Services [ [link removed] ]

Blue Gradient


Agenda for April Drug Utilization Review Board Meeting Now Available

The agenda [ [link removed] ] for the Apr. 28, 2023, Texas Drug Utilization Review Board [ [link removed] ] meeting is now available.

Other news:


* Texas State Plan Public Notice of Intent for Waiver of Drug Counseling Signature Requirements [ [link removed] ]
* Temporary Change in PDL Status for the Neuropathic Pain Drug Class Effective April 3 [ [link removed] ]
* Pharmacy Education Information and Opportunities [ [link removed] ]








________________________________________________________________________

You have subscribed to get updates about Texas Health and Human Services (HHS). For more information about HHS, please visit our website [ [link removed] ].

________________________________________________________________________

Stay Connected Visit us on Facebook [ [link removed] ] Visit us on YouTube [ [link removed] ] Visit us on Twitter [ [link removed] ] Visit us on Instagram [ [link removed] ] Visit us on Facebook [ [link removed] ]  (en español)  

Bookmark and Share [ [link removed] ]

Subscriber Services
Manage Preferences [ [link removed] ]  |  Unsubscribe [ [link removed] ]  |  Help [ [link removed] ]

________________________________________________________________________

This email was sent to [email protected] using govDelivery Communications Cloud on behalf of: Texas Health and Human Services Commission · 707 17th St, Suite 4000 · Denver, CO 80202 GovDelivery logo [ [link removed] ]
Screenshot of the email generated on import

Message Analysis